A Study to Evaluate Allogenic Bone-Marrow Mesenchymal Stromal Cell Product StromaForte in Aging Frailty Patients

NCT06063590 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Aging Frailty

Interventions

BIOLOGICAL: StromaForte

Sponsor

Cellcolabs Clinical SPV Limited

Collaborators

[object Object]